GV

By Jonah Comstock April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...
By Heather Mack April 20, 2017
Digital specialty prescribing platform ZappRx has raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding. ZappRx’s cloud-based platform serves as a conduit for providers, pharmacies and patients to collaborate on the prescribing and management of specialty medications, which are used for complex...
By Heather Mack January 10, 2017
Bethesda, Maryland-based Aledade, which partners with primary care physicians to create tech-enabled accountable care organizations, has raised $20 million in a round led by Biomatics Capital, GV and Maryland Venture Fund. Existing investors Venrock and ARCH Venture Partners also contributed to the round. This brings the company’s total funding to $54.5 million. The funding, which was announced...